Larry J. Black

1.7k total citations · 1 hit paper
16 papers, 1.4k citations indexed

About

Larry J. Black is a scholar working on Genetics, Molecular Biology and Immunology. According to data from OpenAlex, Larry J. Black has authored 16 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 5 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Larry J. Black's work include Estrogen and related hormone effects (13 papers), Reproductive System and Pregnancy (4 papers) and Effects and risks of endocrine disrupting chemicals (2 papers). Larry J. Black is often cited by papers focused on Estrogen and related hormone effects (13 papers), Reproductive System and Pregnancy (4 papers) and Effects and risks of endocrine disrupting chemicals (2 papers). Larry J. Black collaborates with scholars based in United States and United Kingdom. Larry J. Black's co-authors include C. David Jones, Julie F. Falcone, Robin L. Goode, James A. Clemens, William R. Bensch, Raymond F. Kauffman, Ellen R. Rowley, Masahiko Sato, D. Clive Williams and A Bekele and has published in prestigious journals such as Journal of Clinical Investigation, Endocrinology and Journal of Medicinal Chemistry.

In The Last Decade

Larry J. Black

16 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats.

1994 506 citations Larry J. Black, Masahiko Sato et al. Journal of Clinical Investigation profile →

Peers

Countries citing papers authored by Larry J. Black

Since Specialization

Citations

This map shows the geographic impact of Larry J. Black's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Larry J. Black with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Larry J. Black more than expected).

Fields of papers citing papers by Larry J. Black

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Larry J. Black. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Larry J. Black. The network helps show where Larry J. Black may publish in the future.

Co-authorship network of co-authors of Larry J. Black

This figure shows the co-authorship network connecting the top 25 collaborators of Larry J. Black. A scholar is included among the top collaborators of Larry J. Black based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Larry J. Black. Larry J. Black is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Structure–Activity relationships of non-imidazole H3 Receptor ligands. Part 2: binding preference for d-Amino acids motifs 2002 ·Bioorganic & Medicinal Chemistry Letters ·Ramin Faghih, (unknown), Larry J. Black, Huaqing Liu, Robert G. Gentles, (unknown), Timothy A. Esbenshade, (unknown), Thomas R. Miller, (unknown), K. M. Krueger, Gerard B. Fox, Arthur A. Hancock, Youssef L. Bennani	21
2	Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. breakdown → 1994 ·Journal of Clinical Investigation ·Larry J. Black, Masahiko Sato, Ellen R. Rowley, David E. Magee, A Bekele, D. Clive Williams, George J. Cullinan, Raymond A. Bendele, Raymond F. Kauffman, William R. Bensch	506
3	Effects of estrogen and tamoxifen on serum osteocalcin levels in ovariectomized rats 1991 ·Bone and Mineral ·Daniel C. Williams, Donald C. Paul, Larry J. Black	30
4	Inhibition of central nervous system aromatase activity: A mechanism for fenarimol-induced infertility in the male rat 1987 ·Toxicology and Applied Pharmacology ·Kenneth S. Hirsch, (unknown), Larry J. Black, Julie F. Falcone, Neil J. MacLusky	42
5	ChemInform Abstract: ANTIESTROGENS. 2. STRUCTURE‐ACTIVITY STUDIES IN A SERIES OF 3‐AROYL‐2‐ARYLBENZO(B)THIOPHENE DERIVATIVES LEADING TO (6‐HYDROXY‐2‐(4‐HYDROXYPHENYL)BENZO(B)THIEN‐3‐YL)‐(4‐(2‐(1‐PIPERIDINYL)ETHOXY)PHENYL)METHANONE HYDROCHLORIDE (LY 156758), A REMARKABLY EFFECTIVE ESTROGEN ANTAGONIST WITH ONLY MINIMAL INTRINSIC ESTROGENICITY 1985 ·Chemischer Informationsdienst ·C. David Jones, (unknown), Andy Pike, (unknown), Larry J. Black, Allen R. Thompson, Julie F. Falcone, James A. Clemens	1
6	Antiestrogens. 2. Structure-activity studies in a series of 3-aroyl-2-arylbenzo[b]thiophene derivatives leading to [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl]-[4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride (LY 156758), a remarkably effective estrogen antagonist with only minimal intrinsic estrogenicity 1984 ·Journal of Medicinal Chemistry ·Charles D. Jones, (unknown), Andrew Pike, (unknown), Larry J. Black, Allen R. Thompson, Julie F. Falcone, James A. Clemens	240
7	Antagonism of estrogen action with a new benzothiophene derived antiestrogen 1983 ·Life Sciences ·Larry J. Black, C. David Jones, Julie F. Falcone	199
8	Effects of a new antiestrogen, keoxifene (LY156758), on growth of carcinogen-induced mammary tumors and on LH and prolactin levels 1983 ·Life Sciences ·James A. Clemens, (unknown), Larry J. Black, C. David Jones	149
9	EVIDENCE FOR BIOLOGICAL ACTION OF THE ANTIESTROGENS LY117018 AND TAMOXIFEN BY DIFFERENT MECHANISMS 1981 ·Endocrinology ·Larry J. Black, Robin L. Goode	38
10	Differential interaction of antiestrogens with cytosol estrogen receptors 1981 ·Molecular and Cellular Endocrinology ·Larry J. Black, C. David Jones, Robin L. Goode	33
11	Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY117018) in rats and mice 1980 ·Life Sciences ·Larry J. Black, Robin L. Goode	115
12	Synthesis and antiestrogenic activity of [3,4-dihydro-2-(4-methoxyphenyl)-1-naphthalenyl][4-[2-(1-pyrrolidinyl)ethoxy]phenyl]methanone, methanesulfonic acid salt 1979 ·Journal of Medicinal Chemistry ·Charles D. Jones, (unknown), (unknown), Larry J. Black, Frank C. Tinsley	34
13	Complimentary, sequential antifertility effects of chlormadinone and norethindrone in the rabbit: Implications in progestin only fertility control 1975 ·Contraception ·Larry J. Black	2
14	Early Regression of the Progestational Response in Rabbits After Administration of Progestins in the Estrogen Priming Phase 1974 ·Fertility and Sterility ·Larry J. Black	1
15	Evaluation of two types of estrogen inhibition with regard to effects on uptake and binding of [3H]-estradiol in the uterus 1973 ·Journal of Steroid Biochemistry ·Larry J. Black, (unknown)	8
16	The Effect of Estrogen Priming on the Uptake of Radioactive Estradiol 1970 ·Experimental Biology and Medicine ·(unknown), Larry J. Black	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact